The list features leaders who have played pivotal roles in AI adoption CHICAGO,March 17,2025-- Relativity,a global legal technology company,today announced its fourth annual list of AI Visionaries. Th
READ MORESINGAPORE,March 18,2025-- Investbanq,a leading AI-powered wealth management platform,has been recognized by Global Private Banker as the winner in the Best WealthTech Solution – Artificial Intelligen
SUZHOU,China,March 18,2025-- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co.,Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibo
GUANGZHOU,China,April 17,2025-- Once confined to the realm of science fiction,robots are now becoming an integral part of a consumer\'s everyday routines. At the 137th China Import and Export Fair (Ca
Virus-specific T-cell measurement is made easier to enable better understanding of immune responses in patients and management of human infectious diseases.
'A horrific picture of revenge on the part of extraterrestrial creatures, a picture that makes one’s blood freeze.'
In the rapidly evolving Web3 era, innovation and competition go hand in hand. Only platforms with forward-thinking strategies and strong execution capabilities can stand out in the market. Websea is precisely such a rising industry leader.
TAIPEI,March 19,2025-- TÜV Rheinland has issued multiple cTUVus certifications to TeraHive,a solution provider specializing in Intelligent Energy Management. These certifications were awarded to
SHANGHAI,March 19,2025-- Hesai Group (NASDAQ: HSAI) ("Hesai" or the "Company"),the global leader in three-dimensional light detection and ranging (lidar) solutions,today issued the
SHANGHAI,March 19,2025-- Envision Energy,a world-leading green technology company,recently announced its in-house developed and manufactured sliding bearings have been successfully applied on a large
VIENNA,March 19,2025-- The China-Austria Economic and Trade Cooperation Forum,in conjunction with a promotional event for the thirdChina International Supply Chain Expo ("CISCE"),was held i
SHANGHAI,March 19,2025-- Shanghai Henlius Biotech,Inc. (2696.HK) announced that the U.S.Food and Drug Administration(FDA) has granted Orphan Drug Designation (ODD) for HLX22,the company\'s innovativea
© OfficialAffairs